Researchers added virus-like features to mRNA vaccines. In mice, this vaccine caused stronger, longer-lasting immune ...

Researchers conducted the IMPROVE trial to evaluate whether a 3-week pause in BTK inhibitor use would improve immunity after COVID-19 booster vaccination without negatively affecting disease control ...

Patients hospitalized with COVID-linked acute kidney injury are more likely to survive if they are vaccinated than if they ...

The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

Critics fear that U.S. Department of Health and Human Services chief RFK, Jr., known for his antivaccine views, has picked a ...

Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers meet next week, but their agenda suggests they’ll skip ...

Cuts to federal research funding may delay a potential hepatitis B cure, as trials led by UCSF progress. Asian Americans ...

Health authorities and clinicians across China are warning of a significant surge in COVID‑19 infections this July, driven by ...

A research team from The University of Osaka and the Institute of Science Tokyo has developed a class of mRNA medicines that ...

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...